Physician profile
Eric Chow
NPI 1962817676
$2,981.63
in general payments reported to CMS, 2019-2025
8 companies · $582 in 2025
The $582 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.57 · 2021: $261 · 2022: $690 · 2023: $730 · 2024: $634 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,945.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,593.50 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $626.88 | 2022-2025 | Indigo System, Ruby Coil |
| Stryker Corporation | $288.53 | 2023-2025 | Spinejack, Clottriever Bold Catheter, Mild Device Kit |
| Boston Scientific Corporation | $113.55 | 2019-2023 | Spaceoar Vue System - 10ml |
| Teleflex LLC | $112.87 | 2024 | |
| Ge Healthcare | $102.29 | 2024 | |
| Siemens Medical Solutions USA, INC. | $95.94 | 2025 | Somatom X.Cite |
| Medtronic, INC. | $48.07 | 2024-2025 | Solitaire X, Concertotm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.